Sigilon Therapeutics, Inc.
AFIBROTIC COMPOUNDS, DEVICES, AND USES THEREOF
Last updated:
Abstract:
Described herein are compounds of Formula (I), modified polymers and implantable elements comprising compounds of Formula (II), as well as compositions and methods of use thereof. In particular, the compounds, modified polymers, implantable elements and related compositions may be used in methods for the prevention and treatment of a disease, disorder or condition in a subject. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
1 Mar 2019
Issue date:
4 Mar 2021